RESTON,
Va., Oct. 19, 2023 /PRNewswire/ -- Leidos
(NYSE:LDOS), a FORTUNE® 500 science and technology leader, was
recently awarded a next-generation contract to provide the Defense
Health Agency (DHA) with new virtual health capabilities for
providers and patients. The hybrid CPIF/FFP task order was awarded
by DHA's Program Executive Office Defense Healthcare Management
Systems (PEO DHMS). If all options are exercised, the task
order has a 22-month period of performance with a total value of
$180 million.
"Digital First addresses DHA's goal of better outcomes, new
processes, innovation and increased standardization based on
evidence," said Jason McCarthy,
Senior Vice President, Military and Veterans Health Solutions,
Leidos. "As part of our overall MHS GENESIS effort to enhance
patient experience, we, along with Amwell, are looking forward to
delivering this solution for DHA's providers and patients."
Under the contract, the Leidos Partnership for Defense Health
(LPDH) will replace the Military Health System (MHS) Video Connect
solution with Amwell's Converge™ platform. It will start at five
initial sites followed by a phased enterprise roll-out. Digital
First will bring new capabilities and enablement to MHS GENESIS,
including digital technology. Leidos will also provide the
necessary adoptions, support to change management and work
processes to deliver targeted outcomes to MHS GENESIS users.
"Through our world class platform Converge, Amwell is already
enabling hybrid care across the commercial marketplace," said Ido
Schoenberg, M.D., Chairman and CEO of Amwell. "With this agreement,
we are pleased to offer our unique capabilities and help improve
access to quality care for MHS' community of users. We are grateful
for their service and honored to have been chosen to join Leidos in
supporting the Department of Defense as it seeks to adopt and
extend the benefits of hybrid care to the Military Health
System."
Using advanced, evidenced-based and commercially-available
capabilities, LPDH is designed to rapidly deliver an advanced
digital health platform to meet patients where they are. The new
platform includes self-guided wellness and behavioral health
support. This should enable seamless escalation to
on-demand provider engagement to obtain medical care and
advice from any location. Digital First will support the entire
community of MHS GENESIS users, including active-duty service
members, family members, retirees and health professionals across
the continuum of care.
Through integrated platform solutions, Leidos and Amwell will
help reduce burdens on care teams, improve the mental health and
wellness of beneficiaries, help reduce healthcare costs and
optimize the effective utilization of DHA's clinical resources
across their global enterprise.
About Leidos
Leidos is a Fortune 500® technology, engineering, and science
solutions and services leader working to solve the world's toughest
challenges in the defense, intelligence, civil, and health markets.
The company's 46,000 employees support vital missions for
government and commercial customers. Headquartered in Reston, Virginia, Leidos reported annual
revenues of approximately $14.4
billion for the fiscal year ended December 30, 2022. For more information, visit
www.Leidos.com.
Certain statements in this announcement constitute
"forward-looking statements" within the meaning of the rules and
regulations of the U.S. Securities and Exchange Commission (SEC).
These statements are based on management's current beliefs and
expectations and are subject to significant risks and
uncertainties. These statements are not guarantees of future
results or occurrences. A number of factors could cause our actual
results, performance, achievements, or industry results to be
different from the results, performance, or achievements expressed
or implied by such forward-looking statements. These factors
include, but are not limited to, the "Risk Factors" set forth in
Leidos' Annual Report on Form 10-K for the fiscal year ended
December 30, 2022, and other such
filings that Leidos makes with the SEC from time to time.
Readers are cautioned not to place undue reliance on such
forward-looking statements, which speak only as of the date hereof.
Leidos does not undertake to update forward-looking statements to
reflect the impact of circumstances or events that arise after the
date the forward-looking statements were made.
Contact:
Melissa Dueñas
(571) 526-6850
Melissa.L.Duenas@leidos.com
Thomas Doheny
(571) 474-4735
Dohenyt@leidos.com
Lauren Reddington
(202) 924-2226
Lauren.A.Reddington@leidos.com
View original content to download
multimedia:https://www.prnewswire.com/news-releases/leidos-awarded-180m-defense-health-agency-virtual-health-task-order-301961899.html
SOURCE Leidos